Video

Q&A With Carrie Lyn Sammarco From NYU Langone Medical Center: Addressing Quality of Life Issues With Multiple Sclerosis Through Medication And The Benefits of Teamwork

Author(s):

Just as overactive bladder issues and constipation are an issue for patients with multiple sclerosis, mirabegron is a popular medication in the general population for managing these issues. At the NYU Langone Medical Center Comprehensive Care Center patients receive treatment from a wide variety of healthcare professionals in order to get the best results possible for their condition.

Just as overactive bladder issues and constipation are an issue for patients with multiple sclerosis, mirabegron is a popular medication in the general population for managing these issues. A recent study looked at what impact the treatment could have for these patients' quality of life.

Carrie Lyn Sammarco, DrNP, FNP-C, MSCN, from the NYU Langone Medical Center Multiple Sclerosis Comprehensive Care Center discussed how they used the medication to help their patients with this issue during the ECTRIMS conference in Barcelona.

At the center where she works Sammarco said the nurses are part of a larger team where patients receive treatment from a wide variety of healthcare professionals in order to get the best results possible for their condition.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.